newsfilter
← Latest News
GlobeNewswire·

Eikon Therapeutics Announces the Appointment of Ma. Fatima D. Francisco to its Board of Directors

  • Eikon Therapeutics, Inc. (NASDAQ: EIKN) appointed Ma. Fatima ("Fama") D. Francisco as an independent director effective June 15, 2026.
  • Ms. Francisco will serve on the Board's Compensation Committee.
  • She previously served as CEO of the Baby, Feminine & Family Care business unit at Procter & Gamble, leading one of its largest global units over a 35-year career.
  • Ms. Francisco currently serves on the boards of HP Inc. & Nestle S.A. & previously served on the board of Organon & Co.
  • Roger M. Perlmutter, M.D., Ph.D., Chairman & CEO of Eikon, stated Ms. Francisco's expertise in commercial planning & team cultivation will support the company's growth.
  • Ms. Francisco holds a Bachelor of Science degree in Business Administration & Marketing from the University of the Philippines.
  • Eikon is a late-stage clinical biopharmaceutical company focused on oncology, utilizing a single molecule tracking system to develop novel therapies.
  • The press release includes standard forward-looking statements regarding future operations, financial performance, & product development risks.